Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful weapon in the fight against high-grade gliomas, a highly invasive cancer that sends cancerous cells throughout the brain and spinal cord. Chlorotoxin binds specifically to tumor cells–but not normal cells.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • There are nearly 14.5 million people in the U.S. living with a history of cancer.  
  • Thousands of potential cancer medicines in development
     
  • Following the current path, the colon cancer incidence rate will increase by 31.8% between 2003 and 2023 (447,000 people). If an alternative path is taken, there will be 17.7% (79,000…  
  • The 5-year survival rate for all cancers diagnosed from 1996-2003 is 66%, up from 50% in 1975-1977. This improvement reflects progress in early diagnosis and improvements in treatment.  
  • Widespread use of telomerase inhibitors could result in a 50% cure rate and a 25% prolongation of life for 50% of eligible patients with solid tumors.